[Diagnosis and therapy of retinal vein occlusions].
Lang
G E
GE
Universitäts-Augenklinik Ulm. sekretariat.augenklinik@uniklinik-ulm.de
Lang
S J
SJ
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D002986:Clinical Trials as Topic; D003299:Cooperative Behavior; D004596:Electroretinography; D005451:Fluorescein Angiography; D006438:Hemodilution; D006801:Humans; D033183:Interdisciplinary Communication; D053685:Laser Therapy; D054020:Lasers, Gas / Q000627:therapeutic use; D008269:Macular Edema / Q000175:diagnosis / Q000628:therapy; D008487:Medical History Taking; D019721:Ophthalmoscopes; D009887:Ophthalmoscopy; D010348:Patient Care Team; D010808:Physical Examination; D000069579:Ranibizumab; D015861:Retinal Neovascularization / Q000175:diagnosis / Q000628:therapy; D012170:Retinal Vein Occlusion / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D012307:Risk Factors; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000069579:Ranibizumab